Compound Summary
Cyclic AMP
Compound Information
Cyclic AMP
Compound Name: | Cyclic AMP |
Compound CID: | 6076 |
Synonyms: | Cyclic AMP cAMP 60-92-4 Adenosine 3,5-cyclic monophosphate" 3,5-cyclic AMP" More... |
Iupac Name: | (4aR,6R,7R,7aS)-6-(6-aminopurin-9-yl)-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol |
InChI: | InChI=1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/t4-,6-,7-,10-/m1/s1 |
InChIKey: | IVOMOUWHDPKRLL-KQYNXXCUSA-N |
Canonical Smiles: | C1C2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)O)OP(=O)(O1)O |
Isomeric Smiles: | C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)OP(=O)(O1)O |
Molecular Weight: | 329.21 |
Molecular Formula: | C10H12N5O6P |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Cyclic AMP
Molecular Weight: | 329.21 |
Molecular Formula: | C10H12N5O6P |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 10 |
Rotatable Bond Count: | 1 |
Heavy Atom Count: | 22 |
Complexity: | 498 |
Synonyms
Cyclic AMP
| Cyclic AMP | Cyclic AMP |
|---|---|
Cyclic AMP |
cAMP |
60-92-4 |
Adenosine 3,5-cyclic monophosphate" |
3,5-cyclic AMP" |
Adenosine 3,5-cyclophosphate" |
Adenosine 3,5-phosphate |
Adenosine cyclophosphate |
cyclic 3,5-AMP |
Adenosine cyclic monophosphate |
Adenosine-3,5-cyclophosphate" |
cyclic 3,5-Adenylic acid" |
Adenosine 3,5-monophosphate" |
cyclic Adenosine 3,5-phosphate |
Cyclic adenylic acid |
3,5-AMP" |
Adenosine 3,5-cyclic phosphate" |
Adenosine, cyclic 3,5-(hydrogen phosphate)" |
cyclic Adenosine 3,5-monophosphate" |
Adenosine cyclic 3,5-monophosphate" |
Adenosine cyclic 3,5-phosphate |
CCRIS 4291 |
Adenosine cyclic phosphate |
3HcAMP |
Cyclic Adenosine Monophosphate |
3H-cAMP |
UNII-E0399OZS9N |
NSC 94017 |
Acrasin |
adenosine-3,5-cyclic-monophosphate" |
Adenosine 3,5-phosphate monohydrate |
BRN 0052645 |
CHEBI:17489 |
Adenosine cyclicphosphate |
CHEMBL316966 |
E0399OZS9N |
MFCD00005845 |
(4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxy-hexahydro-1,3,5,2$l^{5}-furo3,2-d1,3,2$l^{5}dioxaphosphinin-2-one |
(4aR,6R,7R,7aS)-6-(6-aminopurin-9-yl)-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo3,2-d1,3,2dioxaphosphinin-7-ol |
NCGC00093588-03 |
Adenosine 3,5-cyclic monophosphoric acid |
DSSTox_CID_20436 |
DSSTox_RID_79492 |
DSSTox_GSID_40436 |
114697-05-1 |
adenosine-cyclic-phosphate |
3,5-cAMP |
adenosine cyclic-monophosphate |
adenosine-cyclic-phosphoric-acid |
Siloxanes and Silicones, lauryl Me, Me hydrogen, Me 3-(oxiranylmethoxy)propyl, Me 2-phenylpropyl |
EINECS 200-492-9 |
Adenosine-3,5-cyclic phosphate |
C10H12N5O6P |
Adenosine 3-,5-cyclic monophosphate |
CAS-60-92-4 |
6-(6-Amino-9H-purin-9-yl)tetrahydro-4H-furo3,2-d1,3,2dioxaphosphinine-2,7-diol 2-oxide |
35-cyclic AMP |
CYCLIC AMP; CAMP |
Cyclic 3,5-adenylate |
bmse000071 |
Epitope ID:137352 |
SCHEMBL1244 |
Adenosini Cycloghosghas,(S) |
Lopac0_000084 |
4-26-00-03618 (Beilstein Handbook Reference) |
3 5-adenosine monophosphate |
GTPL2352 |
GTPL5096 |
cAMP; 3,5-Cyclic AMP |
DTXSID8040436 |
BDBM10851 |
cid_23902375 |
HMS3260A10 |
HY-B1511 |
ZINC3873977 |
Tox21_113510 |
Tox21_500084 |
Adenosine-3,5-cyclicmonophosphate |
BDBM50384264 |
s9370 |
Adenosine 3,5-cyclophosphoric acid" |
Adenosine 3:5-cyclic monophosphate" |
Adenosine 3,5-cyclic monophosphorate |
AKOS015999561 |
Cyclic 3,5-monophosphate adenosine |
Tox21_113510_1 |
3, 5-cyclic adenosine monophosphate" |
adenosine 3,5-(hydrogen phosphate) |
CCG-204179 |
DB02527 |
LP00084 |
SDCCGSBI-0050072.P002 |
Adenosine 3a(2),5a(2)-cyclophosphate |
Adenosine-3,5-cyclophosphate (cAMP) |
NCGC00093588-01 |
NCGC00093588-02 |
NCGC00093588-04 |
NCGC00093588-06 |
NCGC00260769-01 |
AS-13112 |
H355 |
Adenosine, 3,5-cyclic-monophosphoric acid |
CS-0013299 |
EU-0100084 |
Adenosine cyclic 3,5-(hydrogen phosphate) |
ADENOSINE-3 ,5 -CYCLIC-MONOPHOSPHATE |
A 9501 |
A51099 |
C00575 |
005C845 |
Q210041 |
SR-01000075695 |
CYCLIC-3,5-(HYDROGEN PHOSPHATE)ADENOSINE |
SR-01000075695-1 |
4H-Furo3,2-d-1,3,2-dioxaphosphorin, adenosine deriv. |
Adenosine 3,5-cyclic phosphate (6CI); Cyclic 3,5- |
B5C9F048-77DD-4170-A624-23C09E7B080D |
Adenosine 3,5-cyclic monophosphate, >=98.5% (HPLC), powder |
Adenosine-3 inverted exclamation mark ,5 inverted exclamation mark -cyclic phosphoric acid |
CAMP;Adenosine 3 inverted exclamation marka,5 inverted exclamation marka-cyclic monophosphat |
(1S,6R,8R,9R)-8-(6-aminopurin-9-yl)-3-hydroxy-3-oxo-2,4,7-trioxa-3$l^{5}-phosphabicyclo4.3.0nonan-9-ol |
(2R,4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)tetrahydro-4H-furo3,2-d1,3,2dioxaphosphinine-2,7-diol 2-oxide |
(4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxy-hexahydro-1,3,5,2$l^{5}-furo3,2-d1,3,2dioxaphosphinin-2-one |
(4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)tetrahydro-4H-furo3,2-d1,3,2dioxaphosphinine-2,7-diol 2-oxide |
(4aR,6R,7R,7aS)-6-(6-Aminopurin-9-yl)-2-oxo-tetrahydro-2-lambda*5*-furo3,2-d1,3,2dioxaphosphinine-2,7-diol |
4H-furo3,2-d-1,3,2-dioxaphosphorin-7-ol, 6-(6-amino-9H-purin-9-yl)tetrahydro-2-hydroxy-, 2-oxide, (4aR,6R,7R,7aS)- |
6-(6-Amino-9H-purin-9-yl)tetrahydro-4H-furo3,2-d1,3,2dioxaphosphinine-2,7-diol 2-oxide # |
Experimental Data
Cyclic AMP
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -10.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
Cyclic AMP
Statistics Data
Cyclic AMP
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -10.000000000000000 | 1 | 1 |
Statistics Data Visualization
Cyclic AMP
